Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Robert M. Sharkey
Synthetic Lethality Exploitation by an Anti–Trop-2-Sn-38 Antibody–Drug Conjugate, IMMU-132, Plus PARP Inhibitors in BRCA1/2 –Wild-Type Triple-Negative Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2-Sn-38 Antibody-Drug Conjugate for the Treatment of Diverse Epithelial Cancers: Safety and Pharmacokinetics
Cancer
Cancer Research
Oncology
Improving the Treatment of Non-Hodgkin Lymphoma With Antibody-Targeted Radionuclides
Cancer
Cancer Research
Oncology
Pretargeted Molecular Imaging and Radioimmunotherapy
Theranostics
Medicine
Toxicology
Pharmaceutics
Pharmacology
Improved18F Labeling of Peptides With a Fluoride-Aluminum-Chelate Complex
Bioconjugate Chemistry
Organic Chemistry
Biotechnology
Pharmacology
Pharmaceutical Science
Bioengineering
Biomedical Engineering
High-Yielding Aqueous18F-Labeling of Peptides via Al18F Chelation
Bioconjugate Chemistry
Organic Chemistry
Biotechnology
Pharmacology
Pharmaceutical Science
Bioengineering
Biomedical Engineering
Sacituzumab Govitecan, a Novel Antibody–Drug Conjugate, in Patients With Metastatic Platinum-Resistant Urothelial Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
